Shilpa Medicare Share price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 18,65,429 shares, with a market capitalization of ₹195581816. Its Average Traded Price (ATP) is ₹952.15, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 30 @ ₹956.15.
Shilpa Medicare has an upper circuit limit of ₹1114.25 and a lower circuit limit of ₹742.85. The total value traded stands at ₹177.62 CR, and the delivery percentage for the day is 42.62%.
The stock is currently traded with a market lot size of 1. Shilpa Medicare also offers a dividend yield of 0.06%.
Shilpa Medicare share price chart
Shilpa Medicare Share Key Metrics
Volume
18.65 L
Market Cap
18700.56 CR
LTQ@LTP
30@956.15
ATP
952.15
Var Margin
100 %
Circuit Range
742.85-1114.25
Delivery %
42.62 %
Value
177.62 CR
ASM/GSM
No
Market Lot
1
Shilpa Medicare Resistance and Support
Pivot 915.48
Resistance
First Resistance
943.91
Second Resistance
959.28
Third Resistance
987.71
Support
First Support
900.11
Second Support
871.68
Third Support
856.31
Shilpa Medicare Shareholding Pattern
View More- 2016-17
- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Shilpa Medicare Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-05 | Quarterly Results |
| 2026-05-22 | Audited Results & Dividend |
| 2026-02-06 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-05-26 | Audited Results & Final Dividend |
| 2025-02-10 | Quarterly Results |
| 2024-11-13 | Quarterly Results |
| 2024-08-08 | Quarterly Results |
| Ex Date | Record Date | |
|---|---|---|
| 2026-09-04 | 2026-09-04 | View More |
| Bonus Date | Record Date | |
|---|---|---|
| 2025-08-13 | 2025-10-03 | View More |
Shilpa Medicare News
Shilpa Medicare Ltd - 530549 - Response On The News Item Captioned 'Shilpa Medicare Recalls Over 27K Vials Of Chemotherapy Drug In US' Published In The Online Edition Of The Economic Times On August 17, 2026 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Shilpa Medicare initiated a voluntary recall of 27,923 vials of Pemetrexed Injection in the United States due to atypical discoloration of the drug product. The US FDA classified this as a Class II recall.
Aug 18 2026 16:10:08
Shilpa Medicare Ltd - 530549 - Final Dividend For The FY 2025-26
Shilpa Medicare announced September 4, 2026, as the Record Date for its FY26 final dividend. Shareholders registered by this date will be eligible for the dividend, to be paid post-AGM approval.
Aug 05 2026 14:14:08
Shilpa Medicare Ltd - 530549 - Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended 30 June, 2026
Shilpa Medicare's Q1 FY27 consolidated revenue increased by 44.89% YoY to ₹465.78 crores, and net profit rose 115.19% YoY to ₹100.88 crores. Additionally, its wholly-owned subsidiary Shilpa Biocare will invest EUR 7 million in Gate2Brain for an equity partnership.
Aug 05 2026 13:50:38
Shilpa Medicare Management
| Name | Position |
|---|---|
| Ritu Tiwary | Company Secretary & Compliance Officer |
| Omprakash Inani | Chairman |
Shilpa Medicare FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in SHILPAMED
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
+ Free 1st Year AMC